IPP Bureau
India's clinical research ambitions need more than regulatory reforms: Experts
By IPP Bureau - June 29, 2026
At the latest Indian Pharma Post E-Conference, leading experts highlighted the need for accredited trial sites, skilled investigators, digital ecosystems, and greater public trust
Health Ministry proposes faster licensing timelines for medical device manufacturers
By IPP Bureau - June 29, 2026
The proposed changes seek to shorten the statutory timelines for granting manufacturing licences across various risk categories
India to launch revamped Anemia Mukt Bharat Abhiyaan with expanded 7x7x7 strategy
By IPP Bureau - June 29, 2026
The transition of the existing Anemia Mukt Bharat programme into Anemia Mukt Bharat Abhiyaan signals a shift towards a more comprehensive, technology-enabled and community-driven approach
Diabetes driving surge in early cataracts among Indians in 40s & 50s
By IPP Bureau - June 29, 2026
India is home to more than 101 million adults living with diabetes and another 136 million with prediabetes
Strides Pharma divests majority stake in Pivot Path for Rs. 100 Cr
By IPP Bureau - June 29, 2026
The deal marks Strides' latest move to monetise high-growth businesses while retaining exposure to their future upside
Johnson & Johnson launches first-in-human SKYWARD trial for carotid IVL system
By IPP Bureau - June 29, 2026
Carotid artery disease accounts for up to 30% of all strokes
Efzimfotase alfa shows strong Phase III results in pediatric hypophosphatasia trial
By IPP Bureau - June 29, 2026
The study also met its key secondary endpoint for bone health
Sanofi Foundation doubles down on children and youth with €15 milliion annual push
By IPP Bureau - June 29, 2026
The Foundation says it is working alongside NGOs, healthcare professionals, patient groups, and local communities to build programs
Otsuka reports strong Phase 3b results for centanafadine XR in adults with ADHD
By IPP Bureau - June 29, 2026
The investigational treatment is showing statistically significant improvements in ADHD symptoms versus placebo at week 8
Roche launches AXELIOS 1 sequencing platform powered by SBX technology
By IPP Bureau - June 29, 2026
Targeting major leap in genomics speed, scale and cost efficiency
Merck names Miguel Alcalde to lead global commercial strategy; Monia Vial to head North America
By IPP Bureau - June 26, 2026
The appointments come as Andrew Paterson, who has spent 31 years with the company, prepares to retire
Merck wins EU nod for KEYTRUDA-Padcev regimen in muscle-invasive bladder cancer
By IPP Bureau - June 26, 2026
The approval is based on results from the pivotal Phase 3 KEYNOTE-905 trial
Reliance-backed Karkinos Healthcare crosses 1 lakh cervical cancer screening in India
By IPP Bureau - June 26, 2026
Karkinos’ model aims to close both gaps by combining World Health Organization-recommended HPV DNA testing with a digitally enabled continuum of care
Eli Lilly seals Centessa acquisition as it bets big on next-gen sleep disorder drugs
By IPP Bureau - June 26, 2026
Centessa is a clinical-stage biotech focused on developing orexin receptor 2 agonists
